Notes
see Reactions 1630 p2; 803210791
Reference
Reuters. Juno ends development of high-profile leukemia drug after deaths. Internet Document : 1 Mar 2017. Available from: URL: http://www.reuters.com/article/us-juno-leukemia-idUSKBN1685QQ
Rights and permissions
About this article
Cite this article
JCAR 015: development ended after deaths. Reactions Weekly 1642, 3 (2017). https://doi.org/10.1007/s40278-017-27180-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-27180-y